Claybrook Capital, LLC Pfizer Inc Transaction History

Claybrook Capital, LLC

$172 Million
Q3 2023

A detailed history of Claybrook Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Claybrook Capital, LLC holds 10,705 shares of PFE stock, worth $280,899. This represents 0.21% of its overall portfolio holdings.

Number of Shares

10,705

Previous 10,500 1.95%

Holding current value

$280,899

Previous $385,000 7.79%

% of portfolio

0.21%

Previous 0.21%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	BUY	$32.09 - $37.51 $6,578 - $7,689	205 Added 1.95%	10,705 $355,000
Q4 2022 Jan 24, 2023	SELL	$41.75 - $54.5 $172,636 - $225,357	-4,135 Reduced 28.25%	10,500 $0
Q2 2022 Jul 18, 2022	SELL	$46.53 - $55.17 $2,326 - $2,758	-50 Reduced 0.34%	14,635 $767,000
Q1 2022 May 06, 2022	SELL	$45.75 - $56.69 $3,431 - $4,251	-75 Reduced 0.51%	14,685 $760,000
Q4 2021 Jan 20, 2022	BUY	$41.32 - $61.25 $3,099 - $4,593	75 Added 0.51%	14,760 $872,000
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $3.3 Million - $4.23 Million	-83,961 Reduced 85.11%	14,685 $632,000
Q2 2021 Jul 26, 2021	BUY	$35.91 - $40.68 $1.9 Million - $2.15 Million	52,961 Added 115.93%	98,646 $3.86 Million
Q4 2020 Feb 02, 2021	BUY	$33.47 - $42.56 $1,673 - $2,128	50 Added 0.11%	45,685 $1.68 Million
Q3 2020 Oct 28, 2020	BUY	$31.75 - $37.25 $47,625 - $55,875	1,500 Added 3.4%	45,635 $1.68 Million
Q2 2020 Jul 29, 2020	BUY	$30.12 - $36.54 $1.33 Million - $1.61 Million	44,135 New	44,135 $1.44 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $142,125 - $156,148	-3,790 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $12,387 - $14,122	-322 Reduced 7.83%	3,790 $156,000
Q1 2018 May 11, 2018	SELL	$31.91 - $37.02 $27,219 - $31,578	-853 Reduced 17.18%	4,112 $146,000
Q4 2017 May 08, 2018	BUY	$33.26 - $35.29 $165,135 - $175,214	4,965	4,965 $180,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Claybrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claybrook Capital, LLC with notifications on news.

Account

Claybrook Capital, LLC Pfizer Inc Transaction History